| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.2M | +154.9% |
| SG&A Expense | $5.1M | -10.1% |
| Operating Income | -$8.3M | -20.3% |
| Pre-tax Income | -$13.2M | -88.5% |
| Net Income | -$13.2M | -157.6% |
| EPS (Basic) | -$2.72 | +24.4% |
| EPS (Diluted) | -$2.72 | +24.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.8M | +32.7% |
| Current Assets | $4.1M | +26.9% |
| Total Assets | $5.0M | +6.5% |
| Current Liabilities | $976K | +49.4% |
| Total Liabilities | $976K | +49.4% |
| Stockholders' Equity | $4.1M | -0.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.9M | -1.7% |
| Investing Cash Flow | $1.5M | +0.0% |
| Financing Cash Flow | $7.8M | +89.9% |